
NYSE:MET
This summary was created by AI, based on 1 opinions in the last 12 months.
Metlife (MET-N) has garnered positive reviews from various experts, particularly highlighting its recent achievement of reaching a 52-week high. The company is regarded as a solid and conservative investment choice, which implies a focus on stability and dependable returns. Experts appreciate Metlife's strategy of being invested in the right sectors, suggesting a well-thought-out approach to risk management and growth potential. As a defensive stock, it is seen as a favorable option, especially during uncertain market conditions. Collectively, the insights indicate a strong belief in Metlife’s resilience and suitability for investors seeking stability.
Metlife is a American stock, trading under the symbol MET (previously MET-N on Stockchase) on the New York Stock Exchange (MET). It is usually referred to as NYSE:MET or MET
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on MET (previously MET-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Metlife.
Metlife was recommended as a Top Pick by Jim Cramer - Mad Money on 2026-06-10. Read the latest stock experts ratings for Metlife.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Metlife.
Metlife is followed by 36 investors on Stockchase and is a trending stock that is worth watching.
On 2026-07-24, Metlife (MET) stock closed at a price of $94.83.
Just made a 52-week high. Solid, conservative and defensive, invested in the right things.